229 related articles for article (PubMed ID: 23845464)
1. Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms.
Jamshidian A; Shaygannejad V; Pourazar A; Zarkesh-Esfahani SH; Gharagozloo M
J Neuroimmunol; 2013 Sep; 262(1-2):106-12. PubMed ID: 23845464
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Jamshidian A; Kazemi M; Shaygannejad V; Salehi M
Iran J Immunol; 2015 Dec; 12(4):311-8. PubMed ID: 26714422
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of regulatory T cells to Th17 cells in IgA nephropathy.
Lin FJ; Jiang GR; Shan JP; Zhu C; Zou J; Wu XR
Scand J Clin Lab Invest; 2012 May; 72(3):221-9. PubMed ID: 22276947
[TBL] [Abstract][Full Text] [Related]
4. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
Peelen E; Damoiseaux J; Smolders J; Knippenberg S; Menheere P; Tervaert JW; Hupperts R; Thewissen M
J Neuroimmunol; 2011 Dec; 240-241():97-103. PubMed ID: 22035960
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
6. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH
PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517
[TBL] [Abstract][Full Text] [Related]
7. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B.
Su ZJ; Yu XP; Guo RY; Ming DS; Huang LY; Su ML; Deng Y; Lin ZZ
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):437-44. PubMed ID: 23747030
[TBL] [Abstract][Full Text] [Related]
8. Impaired balance of Th17/Treg in patients with nasal polyposis.
Shen Y; Tang XY; Yang YC; Ke X; Kou W; Pan CK; Hong SL
Scand J Immunol; 2011 Aug; 74(2):176-85. PubMed ID: 21375554
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
[TBL] [Abstract][Full Text] [Related]
10. TLR2 stimulation regulates the balance between regulatory T cell and Th17 function: a novel mechanism of reduced regulatory T cell function in multiple sclerosis.
Nyirenda MH; Morandi E; Vinkemeier U; Constantin-Teodosiu D; Drinkwater S; Mee M; King L; Podda G; Zhang GX; Ghaemmaghami A; Constantinescu CS; Bar-Or A; Gran B
J Immunol; 2015 Jun; 194(12):5761-74. PubMed ID: 25980006
[TBL] [Abstract][Full Text] [Related]
11. Th17/Treg imbalance in patients with liver cystic echinococcosis.
Tuxun T; Wang JH; Lin RY; Shan JY; Tai QW; Li T; Zhang JH; Zhao JM; Wen H
Parasite Immunol; 2012 Nov; 34(11):520-7. PubMed ID: 22803774
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis.
Schneider-Hohendorf T; Stenner MP; Weidenfeller C; Zozulya AL; Simon OJ; Schwab N; Wiendl H
Eur J Immunol; 2010 Dec; 40(12):3581-90. PubMed ID: 21108477
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
[TBL] [Abstract][Full Text] [Related]
14. Increased peripheral Th17 in patients with pustulosis palmaris et plantaris.
Torii K; Furuhashi T; Saito C; Kato H; Nishioka A; Nishida E; Shintani Y; Morita A
Arch Dermatol Res; 2011 Aug; 303(6):441-4. PubMed ID: 21229362
[TBL] [Abstract][Full Text] [Related]
15. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
[TBL] [Abstract][Full Text] [Related]
17. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
[TBL] [Abstract][Full Text] [Related]
18. Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients.
Bjerg L; Brosbøl-Ravnborg A; Tørring C; Dige A; Bundgaard B; Petersen T; Höllsberg P
J Neuroimmunol; 2012 Aug; 249(1-2):76-82. PubMed ID: 22608884
[TBL] [Abstract][Full Text] [Related]
19. A study on relationship among apoptosis rates, number of peripheral T cell subtypes and disease activity in rheumatoid arthritis.
Ji L; Geng Y; Zhou W; Zhang Z
Int J Rheum Dis; 2016 Feb; 19(2):167-71. PubMed ID: 24618356
[TBL] [Abstract][Full Text] [Related]
20. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
